Business · 19/04/2007Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of New Animal Drug Applications for Estradiol Benzoate
Summary
The Food and Drug Administration (FDA) has withdrawn approval of two new animal drug applications for a suspension implant of estradiol benzoate microspheres, used to increase weight gain and feed efficiency in cattle, due to regulatory changes.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →